Drug studies in humans
Last updated: 2022 Jan 4
Total hit(s): 448
S.No.
1
34677153
Ozone gas applied through nebulization as adjuvant treatment for lung respiratory diseases due to COVID-19 infections: a prospective randomized trial
Med Gas Res
2022 Apr-Jun
1
2
34688919
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
Protein Expr Purif
2022 Feb
1
3
34880010
Convalescent plasma for treatment of COVID-19: study protocol for an open randomised controlled trial in Sweden
BMJ Open
2021 Dec 8
2.49
1
4
34876033
Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report
BMC Infect Dis
2021 Dec 7
2.58
1
5
34863304
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
BMC Res Notes
2021 Dec 4
1.34
2
6
34911695
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline
Eur Respir Rev
2021 Dec 31
4.47
1
7
34933684
Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial
Infect Dis Poverty
2021 Dec 22
3.22
1
8
33220855
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Lancet
2021 Dec 19
43.38
391
9
34898467
[The role of SARS-CoV-2 antibody therapy in the treatment of COVID-19]
Orv Hetil
2021 Dec 19
0.8
1
10
34889410
Passive immune therapies: another tool against COVID-19
Hematology Am Soc Hematol Educ Program
2021 Dec 10
1
11
34898148
Delayed Metastatic Polypoid Nodular Melanoma Diagnosis During COVID-19 Pandemic, Successful Treatment With Surgery and Nivolumab
J Drugs Dermatol
2021 Dec 1
2.1
1
12
34889950
Trustworthy Clinical Practice Guidelines of Pharmacological Treatments for Hospitalized Patients With COVID-19-A Scarce Resource
JAMA Netw Open
2021 Dec 1
5.032
1
13
34727009
Vitamin D levels and oxidative stress markers in patients hospitalized with COVID-19
Redox Rep
2021 Dec
1
14
33538646
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection
Emerg Microbes Infect
2021 Dec
5.84
9
15
34704822
Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19
Biomark Med
2021 Dec
2.09
1
16
34887303
Changes in respiratory diseases in South Korea during the COVID-19 pandemic: an interrupted time series study
BMJ Glob Health
2021 Dec
N/A
1
17
34737165
Antinuclear antibodies (ANAs) detected by indirect immunofluorescence (IIF) method in acute COVID-19 infection; future roadmap for laboratory diagnosis
J Immunol Methods
2021 Dec
1.91
1
18
33830901
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort
Emerg Microbes Infect
2021 Dec
5.84
11
19
33860730
From nicotine to the cholinergic anti-inflammatory reflex - Can nicotine alleviate the dysregulated inflammation in COVID-19?
J Immunotoxicol
2021 Dec
3
20
34688149
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
Int Immunopharmacol
2021 Dec
3.38
4
21
34346827
Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody
Emerg Microbes Infect
2021 Dec
5.84
1
22
34511338
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
Eur J Intern Med
2021 Dec
3.05
2
23
34710657
Immunopathological events surrounding IL-6 and IFN-α: A bridge for anti-lupus erythematosus drugs used to treat COVID-19
Int Immunopharmacol
2021 Dec
3.38
1
24
34057040
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine
Emerg Microbes Infect
2021 Dec
5.84
7
25
34487951
Impact of early versus late administration of bamlanivimab on readmissions in patients with high-risk COVID-19
Am J Emerg Med
2021 Dec
1.68
1